...
首页> 外文期刊>The European respiratory journal : >Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort
【24h】

Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort

机译:患者报告的痛苦可以帮助特发性肺纤维化的临床决策:剖面队列分析

获取原文
获取原文并翻译 | 示例
           

摘要

Idiopathic pulmonary fibrosis is a progressive and fatal interstitial lung disease. We aimed to determine if patient response to a palliative assessment survey could predict disease progression or death. We undertook a cross-sectional study in a UK clinical cohort of incident cases. Rasch-based methodology provided a disease distress value from an abridged 11-item model of the original 45-item survey. Distress values were compared with measures of lung function. Disease progression or mortality alone was predicted at 12 months from survey completion, with risk of death assessed at 3, 6 and 12 months. Disease distress values were negatively correlated with lung function (r=-0.275 for the percentage predicted diffusing capacity of the lung for carbon monoxide). Expected survey scores computed from distress values could distinguish disease progression (n=8.8, p=0.004) and death (n=10.2, p=0.002) from no disease progression (n=6.9). Actual survey scores predicted disease progression and death with an area under the curve of 0.60 and 0.64, respectively. Each point increment in actual score increased risk of 12-month mortality by 10%; almost 43% of people scoring above 18 did not survive beyond 105 days. We define a short questionnaire that can score disease distress and predict prognosis, thus assisting clinical decision-making in progressive fibrosis.
机译:特发性肺纤维化是一种渐进性和致命的间质性肺病。我们旨在确定患者对姑息性评估调查的反应是否可以预测疾病进展或死亡。我们在英国临床队列的事件案件中进行了横断面研究。基于RASCH的方法提供了来自原始45项调查的删节11项模型的疾病遇险值。将痛苦值与肺功能措施进行比较。从调查完成后12个月预测疾病进展或死亡率,死亡风险在3,6和12个月内评估。疾病遇险值与肺功能呈负相关(R = -0.275,用于肺部肺的肺部延伸能力的百分比)。从遇险值计算的预期调查分数可以区分疾病进展(n = 8.8,p = 0.004)和死亡(n = 10.2,p = 0.002),无疾病进展(n = 6.9)。实际测量评分预测疾病进展和死亡分别为0.60和0.64曲线下的面积。每个点的实际比分增量增加了12个月死亡率的风险增加10%;近43%的人在18岁以上不超过105天内存活。我们定义了一项简短的问卷,可以得分疾病痛苦和预测预后,从而协助临床决策进行渐进式纤维化。

著录项

  • 来源
    《The European respiratory journal :》 |2019年第5期|共10页
  • 作者单位

    Nottingham Univ Hosp NHS Trust Natl Inst Hlth Res Nottingham Biomed Res Ctr Nottingham England;

    Univ Nottingham Div Resp Med Resp Res Unit Nottingham England;

    Nottingham Univ Hosp NHS Trust Natl Inst Hlth Res Nottingham Biomed Res Ctr Nottingham England;

    GlaxoSmithKline Med Res Ctr GlaxoSmithKline R&

    D Fibrosis Discovery Performance Unit Stevenage;

    GlaxoSmithKline Med Res Ctr GlaxoSmithKline R&

    D Fibrosis Discovery Performance Unit Stevenage;

    Royal Brompton Hosp Resp Biomed Res Unit Natl Inst Hlth Res London England;

    GlaxoSmithKline Med Res Ctr GlaxoSmithKline R&

    D Fibrosis Discovery Performance Unit Stevenage;

    GlaxoSmithKline Med Res Ctr GlaxoSmithKline R&

    D Fibrosis Discovery Performance Unit Stevenage;

    GlaxoSmithKline Med Res Ctr GlaxoSmithKline R&

    D Fibrosis Discovery Performance Unit Stevenage;

    Nottingham Univ Hosp NHS Trust Natl Inst Hlth Res Nottingham Biomed Res Ctr Nottingham England;

    Nottingham Univ Hosp NHS Trust Natl Inst Hlth Res Nottingham Biomed Res Ctr Nottingham England;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 呼吸系及胸部疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号